Every filing for G75228109 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Commodore Capital LP
13G/A
Amendment 2
|
0% |
11/16/2026
Event 9/30/2026
|
|
| Commodore Capital LP | 0% | ||
| Commodore Capital Master LP | 0% | ||
| Robert Egen Atkinson | 0% | ||
| Michael Kramarz | 0% | ||
|
Perceptive Advisors LLC
13G/A
Amendment 1
|
9.0% |
11/16/2026
Event 9/30/2026
|
|
| Perceptive Advisors LLC | 9.0% | ||
| Joseph Edelman | 9.0% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 9.0% | ||
|
Balyasny Asset Management L.P.
13G
|
5.1% |
11/16/2026
Event 9/30/2026
|
|
| Balyasny Asset Management L.P. | 5.1% | ||
| Bam GP LLC | 5.1% | ||
| Balyasny Asset Management Holdings LP | 5.1% | ||
| Dames GP LLC | 5.1% | ||
| Dmitry Balyasny | 5.1% | ||
|
ADAR1 Capital Management, LLC
13G
|
6.8% |
11/16/2026
Event 9/30/2026
|
|
| ADAR1 Capital Management, LLC | 6.8% | ||
| Daniel Schneeberger | 6.8% | ||
|
Sirenia Capital Management LP
13G
|
6.6% |
11/16/2026
Event 9/30/2026
|
|
| Sirenia Capital Management LP | 6.6% | ||
| Alex Silverstein | 6.6% | ||
|
Spruce Street Capital LP
13G
|
5.8% |
11/13/2026
Event 9/30/2026
|
|
| Spruce Street Capital LP | 5.8% | ||
| Alex R. Rosen | 5.8% | ||
| Simon Basseyn | 5.8% | ||
|
Research Alliance Holdings IV LLC
13D
|
17.0% |
7/21/2026
Event 7/14/2026
|
|
| Research Alliance Holdings IV LLC | 17.0% | ||
| Matthew Hammond | 17.0% | ||
|
Trails Edge Capital Partners, LP
13G
|
5.5% |
7/21/2026
Event 7/14/2026
|
|
| Trails Edge Capital Partners, LP | 5.5% | ||
| Trails Edge Biotechnology Master Fund, LP | 5.5% | ||
| Ortav Yehudai | 5.5% | ||
|
Commodore Capital LP
13G
|
5.5% |
7/20/2026
Event 7/13/2026
|
|
| Commodore Capital LP | 5.5% | ||
| Commodore Capital Master LP | 5.5% | ||
| Robert Egen Atkinson | 5.5% | ||
| Michael Kramarz | 5.5% | ||
|
Perceptive Advisors LLC
13G
|
7.7% |
7/20/2026
Event 7/13/2026
|
|
| Perceptive Advisors LLC | 7.7% | ||
| Joseph Edelman | 7.7% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 7.7% | ||
|
Biotechnology Value Fund L P
13G
|
6.4% |
7/20/2026
Event 7/13/2026
|
|
| Biotechnology Value Fund L P | 3.4% | ||
| BVF I GP LLC | 3.4% | ||
| Biotechnology Value Fund II LP | 2.5% | ||
| BVF II GP LLC | 2.5% | ||
| Biotechnology Value Trading Fund OS LP | 0.4% | ||
| BVF Partners OS Ltd. | 0.4% | ||
| BVF GP Holdings LLC | 5.9% | ||
| BVF Partners L P/IL | 6.4% | ||
| BVF Inc/IL | 6.4% | ||
| Lampert Mark N | 6.4% |
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 25 | 6.83 M | $80.9M |